NCT04572750View on ClinicalTrials.gov

Promoting Benzodiazepine Cessation Through an Electronically-delivered Patient Self-management Intervention

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

July 3, 2024

Study Completion Date

July 3, 2024

Conditions
Taking Benzodiazepines for Any Reason for 3 MonthsBenzodiazepine Dependence
Interventions
BEHAVIORAL

EMPOWER-ED

An electronic app that runs on a variety of platforms and provides education and tools designed to promote self-driven reduction of benzodiazepines.

Trial Locations (1)

94304-1207

VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto

All Listed Sponsors
lead

VA Office of Research and Development

FED